 | • レポートコード：QYR9ST04056 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のモンテルカスト中間体市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。モンテルカスト中間体の種類別には、GMP、非GMPに、用途別には、喘息、アレルギー性鼻炎、気管支痙攣、U麻疹に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・モンテルカスト中間体の種類別市場規模：GMP、非GMP ・モンテルカスト中間体の用途別市場規模：喘息、アレルギー性鼻炎、気管支痙攣、U麻疹 ・モンテルカスト中間体の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：VIVAN Life Sciences、P.G. Shah & Co.、Manus Aktteva Biopharma、Ortin Laboratories ・市場規模予測2019-2025：生産量 ・市場規模予測2019-2025：消費量 ・バリューチェーン・販売チャネル分析 ・市場機会・課題分析 ... |
Montelukast Intermediate is a leukotriene receptor antagonist (LTRA)Montelukast Intermediate used to prevent wheezing, difficulty in breathing, chest tightness, and coughing caused by asthma.
In 2018, the global Montelukast Intermediate market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Montelukast Intermediate.
This study researches the market size of Montelukast Intermediate, presents the global Montelukast Intermediate sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Montelukast Intermediate in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Montelukast Intermediate for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.
This report includes the following manufacturers; we can also add the other companies as you want.
P.G. Shah & Co.
Manus Aktteva Biopharma
Ortin Laboratories
…
Market Segment by Product Type
GMP
Non-GMP
Market Segment by Application
Asthma
Allergic Rhinitis
Bronchospasm
Urticaria
Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives are:
To analyze and research the global Montelukast Intermediate status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Montelukast Intermediate manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Montelukast Intermediate are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Montelukast Intermediate Market Size Growth Rate by Type
1.3.2 GMP
1.3.3 Non-GMP
1.4 Market Segment by Application
1.4.1 Global Montelukast Intermediate Market Share by Application (2019-2025)
1.4.2 Asthma
1.4.3 Allergic Rhinitis
1.4.4 Bronchospasm
1.4.5 Urticaria
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Montelukast Intermediate Market Size
2.1.1 Global Montelukast Intermediate Revenue 2014-2025
2.1.2 Global Montelukast Intermediate Sales 2014-2025
2.2 Montelukast Intermediate Growth Rate by Regions
2.2.1 Global Montelukast Intermediate Sales by Regions 2014-2019
2.2.2 Global Montelukast Intermediate Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Montelukast Intermediate Sales by Manufacturers
3.1.1 Montelukast Intermediate Sales by Manufacturers 2014-2019
3.1.2 Montelukast Intermediate Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Montelukast Intermediate Revenue by Manufacturers (2014-2019)
3.2.2 Montelukast Intermediate Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Montelukast Intermediate Market Concentration Ratio (CR5 and HHI)
3.3 Montelukast Intermediate Price by Manufacturers
3.4 Key Manufacturers Montelukast Intermediate Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Montelukast Intermediate Market
3.6 Key Manufacturers Montelukast Intermediate Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 GMP Sales and Revenue (2014-2019)
4.1.2 Non-GMP Sales and Revenue (2014-2019)
4.2 Global Montelukast Intermediate Sales Market Share by Type
4.3 Global Montelukast Intermediate Revenue Market Share by Type
4.4 Montelukast Intermediate Price by Type
5 Market Size by Application
5.1 Overview
5.1 Global Montelukast Intermediate Sales by Application
6 North America
6.1 North America Montelukast Intermediate Breakdown Data by Company
6.2 North America Montelukast Intermediate Breakdown Data by Type
6.3 North America Montelukast Intermediate Breakdown Data by Application
6.4 North America Montelukast Intermediate Breakdown Data by Countries
6.4.1 North America Montelukast Intermediate Sales by Countries
6.4.2 North America Montelukast Intermediate Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
7 Europe
7.1 Europe Montelukast Intermediate Breakdown Data by Company
7.2 Europe Montelukast Intermediate Breakdown Data by Type
7.3 Europe Montelukast Intermediate Breakdown Data by Application
7.4 Europe Montelukast Intermediate Breakdown Data by Countries
7.4.1 Europe Montelukast Intermediate Sales by Countries
7.4.2 Europe Montelukast Intermediate Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Montelukast Intermediate Breakdown Data by Company
8.2 Asia Pacific Montelukast Intermediate Breakdown Data by Type
8.3 Asia Pacific Montelukast Intermediate Breakdown Data by Application
8.4 Asia Pacific Montelukast Intermediate Breakdown Data by Countries
8.4.1 Asia Pacific Montelukast Intermediate Sales by Countries
8.4.2 Asia Pacific Montelukast Intermediate Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam
9 Central & South America
9.1 Central & South America Montelukast Intermediate Breakdown Data by Company
9.2 Central & South America Montelukast Intermediate Breakdown Data by Type
9.3 Central & South America Montelukast Intermediate Breakdown Data by Application
9.4 Central & South America Montelukast Intermediate Breakdown Data by Countries
9.4.1 Central & South America Montelukast Intermediate Sales by Countries
9.4.2 Central & South America Montelukast Intermediate Revenue by Countries
9.4.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa Montelukast Intermediate Breakdown Data by Type
10.2 Middle East and Africa Montelukast Intermediate Breakdown Data by Application
10.3 Middle East and Africa Montelukast Intermediate Breakdown Data by Countries
10.3.1 Middle East and Africa Montelukast Intermediate Sales by Countries
10.3.2 Middle East and Africa Montelukast Intermediate Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa
11 Company Profiles
11.1 VIVAN Life Sciences
11.1.1 VIVAN Life Sciences Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Montelukast Intermediate
11.1.4 Montelukast Intermediate Product Introduction
11.1.5 VIVAN Life Sciences Recent Development
11.2 P.G. Shah & Co.
11.2.1 P.G. Shah & Co. Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Montelukast Intermediate
11.2.4 Montelukast Intermediate Product Introduction
11.2.5 P.G. Shah & Co. Recent Development
11.3 Manus Aktteva Biopharma
11.3.1 Manus Aktteva Biopharma Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Montelukast Intermediate
11.3.4 Montelukast Intermediate Product Introduction
11.3.5 Manus Aktteva Biopharma Recent Development
11.4 Ortin Laboratories
11.4.1 Ortin Laboratories Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Montelukast Intermediate
11.4.4 Montelukast Intermediate Product Introduction
11.4.5 Ortin Laboratories Recent Development
12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Montelukast Intermediate Sales Channels
12.2.2 Montelukast Intermediate Distributors
12.3 Montelukast Intermediate Customers
13 Market Forecast
13.1 Global Montelukast Intermediate Sales and Revenue Forecast 2019-2025
13.2 Global Montelukast Intermediate Sales Forecast by Type
13.3 Global Montelukast Intermediate Sales Forecast by Application
13.4 Montelukast Intermediate Forecast by Regions
13.4.1 Global Montelukast Intermediate Sales Forecast by Regions 2019-2025
13.4.2 Global Montelukast Intermediate Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Montelukast Intermediate Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Montelukast Intermediate Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Montelukast Intermediate Sales Forecast by Countries 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Montelukast Intermediate Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Montelukast Intermediate Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Figure Montelukast Intermediate Product Picture
Table Montelukast Intermediate Key Market Segments
Table Major Manufacturers Montelukast Intermediate Covered in This Report
Table Global Montelukast Intermediate Market Size Growth Rate by Type 2019-2025 (MT) & (Million US$)
Figure Global Montelukast Intermediate Sales Market Shar by Type 2014-2025
Figure GMP Figures
Table Major Manufacturers of GMP
Figure Non-GMP Figures
Table Major Manufacturers of Non-GMP
Table Global Montelukast Intermediate Market Share by Application 2019-2025 (MT)
Figure Asthma Use Case
Figure Allergic Rhinitis Use Case
Figure Bronchospasm Use Case
Figure Urticaria Use Case
Figure Montelukast Intermediate Report Years Considered
Figure Global Montelukast Intermediate Market Size 2014-2025 (Million US$)
Figure Global Montelukast Intermediate Sales 2014-2019 (MT)
Table Global Montelukast Intermediate Market Size by Regions 2014-2019 (MT) & (Million US$)
Table Global Montelukast Intermediate Sales by Regions 2014-2019 (MT)
Table Global Montelukast Intermediate Sales Market Share by Regions 2014-2019
Figure Global Montelukast Intermediate Sales Market Share by Regions 2014-2019
Figure Global Montelukast Intermediate Sales Market Share by Regions in 2018
Table Global Montelukast Intermediate Revenue by Regions 2014-2019 (Million US$)
Table Global Montelukast Intermediate Revenue Market Share by Regions 2014-2019
Figure Global Montelukast Intermediate Revenue Market Share by Regions 2014-2019
Figure Global Montelukast Intermediate Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Montelukast Intermediate Sales by Manufacturers (2014-2019) (MT)
Table Global Montelukast Intermediate Sales Share by Manufacturers (2014-2019)
Figure Global Montelukast Intermediate Sales Share by Manufacturers in 2018
Table Montelukast Intermediate Revenue by Manufacturers (2014-2019) (Million USD)
Table Montelukast Intermediate Revenue Share by Manufacturers (2014-2019)
Figure Montelukast Intermediate Value Share by Manufacturers in 2018
Table Global Montelukast Intermediate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Montelukast Intermediate Price (2014-2019) (USD/MT)
Table Key Manufacturers Montelukast Intermediate Plants/Factories Distribution
Table Key Manufacturers Montelukast Intermediate Area Served
Table Date of Key Manufacturers Enter into Montelukast Intermediate Market
Table Key Manufacturers Montelukast Intermediate Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global GMP Sales an目录输出!D Revenue (2014-2019) (MT) & (Million US$)
Table Global Non-GMP Sales an目录输出!D Revenue (2014-2019) (MT) & (Million US$)
Table Global Montelukast Intermediate Sales by Type (2014-2019) (MT)
Table Global Montelukast Intermediate Sales Share by Type (2014-2019)
Figure Global Montelukast Intermediate Sales Market Share by Type (2014-2019)
Figure Global Montelukast Intermediate Sales Market Share by Type in 2018
Table Global Montelukast Intermediate Revenue by Type (2014-2019) (Million US$)
Table Global Montelukast Intermediate Revenue Share by Type (2014-2019)
Figure Global Montelukast Intermediate Revenue Market Share by Type (2014-2019)
Figure Global Montelukast Intermediate Revenue Market Share by Type in 2018
Table Montelukast Intermediate Price by Type 2014-2019 (USD/MT)
Table Global Montelukast Intermediate Sales by Application (2014-2019) (MT)
Table Global Montelukast Intermediate Sales Share by Application (2014-2019)
Figure Global Sales Montelukast Intermediate Market Share by Application (2014-2019)
Figure Global Sales Montelukast Intermediate Market Share by Application in 2018
Figure North America Montelukast Intermediate Sales Growth Rate 2014-2019 (MT)
Figure North America Montelukast Intermediate Revenue Growth Rate 2014-2019 (Million US$)
Table North America Montelukast Intermediate Sales by Company (2014-2019) (MT)
Table North America Montelukast Intermediate Sales Market Share by Company (2014-2019)
Figure North America Montelukast Intermediate Sales Market Share by Company in 2018
Table North America Montelukast Intermediate Sales by Type (2014-2019) (MT)
Table North America Montelukast Intermediate Sales Market Share by Type (2014-2019)
Figure North America Montelukast Intermediate Market Share by Type in 2018
Table North America Montelukast Intermediate Sales by Application (2014-2019) (MT)
Table North America Montelukast Intermediate Sales Market Share by Application (2014-2019)
Figure North America Montelukast Intermediate Market Share by Application in 2018
Table North America Montelukast Intermediate Sales by Countries (2014-2019) (MT)
Table North America Montelukast Intermediate Sales Market Share by Countries (2014-2019)
Figure North America Montelukast Intermediate Sales Market Share by Countries in 2018
Table North America Montelukast Intermediate Revenue by Countries (2014-2019) (Million US$)
Table North America Montelukast Intermediate Revenue Market Share by Countries (2014-2019)
Figure North America Montelukast Intermediate Revenue Market Share by Countries in 2018
Figure United States Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure Canada Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure Mexico Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure Europe Montelukast Intermediate Sales Growth Rate 2014-2019 (MT)
Figure Europe Montelukast Intermediate Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Montelukast Intermediate Sales by Company (2014-2019) (MT)
Table Europe Montelukast Intermediate Sales Market Share by Company (2014-2019)
Figure Europe Montelukast Intermediate Sales Market Share by Company in 2018
Table Europe Montelukast Intermediate Sales by Type (2014-2019) (MT)
Table Europe Montelukast Intermediate Sales Market Share by Type (2014-2019)
Figure Europe Montelukast Intermediate Sales Market Share by Type in 2018
Table Europe Montelukast Intermediate Sales by Application (2014-2019) (MT)
Table Europe Montelukast Intermediate Sales Market Share by Application (2014-2019)
Figure Europe Montelukast Intermediate Sales Market Share by Application in 2018
Table Europe Montelukast Intermediate Sales by Countries (2014-2019) (MT)
Table Europe Montelukast Intermediate Sales Market Share by Countries (2014-2019)
Figure Europe Montelukast Intermediate Sales Market Share by Countries in 2018
Table Europe Montelukast Intermediate Revenue by Countries (2014-2019) (Million US$)
Table Europe Montelukast Intermediate Revenue Market Share by Countries (2014-2019)
Figure Europe Montelukast Intermediate Revenue Market Share by Countries in 2018
Figure Germany Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure France Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure UK Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure Italy Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure Russia Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure Asia Pacific Montelukast Intermediate Sales Growth Rate 2014-2019 (MT)
Figure Asia Pacific Montelukast Intermediate Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Montelukast Intermediate Sales by Company (2014-2019) (MT)
Table Asia Pacific Montelukast Intermediate Sales Market Share by Company (2014-2019)
Figure Asia Pacific Montelukast Intermediate Sales Market Share by Company in 2018
Table Asia Pacific Montelukast Intermediate Sales by Type (2014-2019) (MT)
Table Asia Pacific Montelukast Intermediate Sales Market Share by Type (2014-2019)
Figure Asia Pacific Montelukast Intermediate Market Share by Type in 2018
Table Asia Pacific Montelukast Intermediate Sales by Application (2014-2019) (MT)
Table Asia Pacific Montelukast Intermediate Sales Market Share by Application (2014-2019)
Figure Asia Pacific Montelukast Intermediate Market Share by Application in 2018
Table Asia Pacific Montelukast Intermediate Sales by Countries (2014-2019) (MT)
Table Asia Pacific Montelukast Intermediate Sales Market Share by Countries (2014-2019)
Figure Asia Pacific Montelukast Intermediate Sales Market Share by Countries in 2018
Table Asia Pacific Montelukast Intermediate Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Montelukast Intermediate Revenue Market Share by Countries (2014-2019)
Figure Asia Pacific Montelukast Intermediate Revenue Market Share by Countries in 2018
Figure China Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure China Montelukast Intermediate Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure Japan Montelukast Intermediate Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure Korea Montelukast Intermediate Revenue Growth Rate (2014-2019) (Million US$)
Figure India Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure India Montelukast Intermediate Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure Australia Montelukast Intermediate Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure Indonesia Montelukast Intermediate Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure Malaysia Montelukast Intermediate Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure Philippines Montelukast Intermediate Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure Thailand Montelukast Intermediate Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure Vietnam Montelukast Intermediate Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Montelukast Intermediate Sales Growth Rate 2014-2019 (MT)
Figure Central & South America Montelukast Intermediate Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Montelukast Intermediate Sales by Company (2014-2019) (MT)
Table Central & South America Montelukast Intermediate Sales Market Share by Company (2014-2019)
Figure Central & South America Montelukast Intermediate Sales Market Share by Company in 2018
Table Central & South America Montelukast Intermediate Sales by Type (2014-2019) (MT)
Table Central & South America Montelukast Intermediate Sales Market Share by Type (2014-2019)
Figure Central & South America Montelukast Intermediate Market Share by Type in 2018
Table Central & South America Montelukast Intermediate Sales by Application (2014-2019) (MT)
Table Central & South America Montelukast Intermediate Sales Market Share by Application (2014-2019)
Figure Central & South America Montelukast Intermediate Market Share by Application in 2018
Table Central & South America Montelukast Intermediate Sales by Countries (2014-2019) (MT)
Table Central & South America Montelukast Intermediate Sales Market Share by Countries (2014-2019)
Figure Central & South America Montelukast Intermediate Sales Market Share by Countries in 2018
Table Central & South America Montelukast Intermediate Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Montelukast Intermediate Revenue Market Share by Countries (2014-2019)
Figure Central & South America Montelukast Intermediate Revenue Market Share by Countries in 2018
Figure Brazil Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure Brazil Montelukast Intermediate Revenue Growth Rate (2014-2019) (MT)
Figure Middle East and Africa Montelukast Intermediate Sales Growth Rate 2014-2019 (MT)
Figure Middle East and Africa Montelukast Intermediate Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Montelukast Intermediate Sales by Type (2014-2019) (MT)
Table Middle East and Africa Montelukast Intermediate Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Montelukast Intermediate Sales Market Share by Type in 2018
Table Middle East and Africa Montelukast Intermediate Sales by Application (2014-2019) (MT)
Table Middle East and Africa Montelukast Intermediate Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Montelukast Intermediate Sales Market Share by Application in 2018
Table Middle East and Africa Montelukast Intermediate Sales by Countries (2014-2019) (MT)
Table Middle East and Africa Montelukast Intermediate Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Montelukast Intermediate Sales Market Share by Countries in 2018
Table Middle East and Africa Montelukast Intermediate Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Montelukast Intermediate Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Montelukast Intermediate Revenue Market Share by Countries in 2018
Figure GCC Countries Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure GCC Countries Montelukast Intermediate Revenue Growth Rate (2014-2019) (MT)
Figure Egypt Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure Egypt Montelukast Intermediate Revenue Growth Rate (2014-2019) (MT)
Figure South Africa Montelukast Intermediate Sales Growth Rate (2014-2019) (MT)
Figure South Africa Montelukast Intermediate Revenue Growth Rate (2014-2019) (MT)
Table VIVAN Life Sciences Company Details
Table VIVAN Life Sciences Description and Business Overview
Table VIVAN Life Sciences Montelukast Intermediate Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table VIVAN Life Sciences Montelukast Intermediate Sales Growth Rate (2014-2019)
Table VIVAN Life Sciences Montelukast Intermediate Sales Market Share in Global Market
Table VIVAN Life Sciences Recent Development
Table P.G. Shah & Co. Company Details
Table P.G. Shah & Co. Description and Business Overview
Table P.G. Shah & Co. Montelukast Intermediate Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table P.G. Shah & Co. Montelukast Intermediate Sales Growth Rate (2014-2019)
Table P.G. Shah & Co. Montelukast Intermediate Sales Market Share in Global Market
Table P.G. Shah & Co. Recent Development
Table Manus Aktteva Biopharma Company Details
Table Manus Aktteva Biopharma Description and Business Overview
Table Manus Aktteva Biopharma Montelukast Intermediate Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Manus Aktteva Biopharma Montelukast Intermediate Sales Growth Rate (2014-2019)
Table Manus Aktteva Biopharma Montelukast Intermediate Sales Market Share in Global Market
Table Manus Aktteva Biopharma Recent Development
Table Ortin Laboratories Company Details
Table Ortin Laboratories Description and Business Overview
Table Ortin Laboratories Montelukast Intermediate Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Ortin Laboratories Montelukast Intermediate Sales Growth Rate (2014-2019)
Table Ortin Laboratories Montelukast Intermediate Sales Market Share in Global Market
Table Ortin Laboratories Recent Development
Figure Montelukast Intermediate Value Chain
Table Montelukast Intermediate Distributors List
Table Montelukast Intermediate Customers List
Table Global Montelukast Intermediate Sales Forecast 2019-2025 (MT) & (Million US$)
Figure Global Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Figure Global Montelukast Intermediate Revenue Forecast 2019-2025 (Million US$)
Table Global Montelukast Intermediate Sales Forecast by Type 2019-2025 (MT)
Figure Global Montelukast Intermediate Sales Forecast by Type 2019-2025 (MT)
Figure Global Montelukast Intermediate Sales Market Share Forecast by Type 2019-2025
Table Global Montelukast Intermediate Sales Forecast by Application 2019-2025 (MT)
Figure Global Montelukast Intermediate Sales Forecast by Application 2019-2025 (MT)
Figure Global Montelukast Intermediate Sales Market Share Forecast by Application 2019-2025
Table Global Montelukast Intermediate Sales Forecast by Regions 2019-2025 (MT)
Figure Global Montelukast Intermediate Sales Forecast by Regions 2019-2025 (MT)
Figure Global Montelukast Intermediate Sales Market Share Forecast by Regions 2019-2025
Table Global Montelukast Intermediate Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Montelukast Intermediate Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Montelukast Intermediate Revenue Market Share Forecast by Regions 2019-2025
Table North America Montelukast Intermediate Sales Forecast by Countries 2019-2025 (MT)
Table North America Montelukast Intermediate Sales Market Share Forecast by Countries 2019-2025
Table North America Montelukast Intermediate Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Montelukast Intermediate Revenue Market Share Forecast by Countries 2019-2025
Figure United States Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Figure Canada Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Figure Mexico Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Table Europe Montelukast Intermediate Sales Forecast by Countries 2019-2025 (MT)
Table Europe Montelukast Intermediate Sales Market Share Forecast by Countries 2019-2025
Table Europe Montelukast Intermediate Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Montelukast Intermediate Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Figure France Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Figure UK Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Figure Italy Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Figure Russia Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Table Asia Pacific Montelukast Intermediate Sales Forecast by Countries 2019-2025 (MT)
Table Asia Pacific Montelukast Intermediate Sales Market Share Forecast by Countries 2019-2025
Table Asia Pacific Montelukast Intermediate Revenue Forecast by Countries 2019-2025 (Million US$)
Table Asia Pacific Montelukast Intermediate Revenue Market Share Forecast by Countries 2019-2025
Figure China Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Figure Japan Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Figure South Korea Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Figure India Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Figure Australia Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Figure Indonesia Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Figure Thailand Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Figure Malaysia Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Figure Philippines Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Figure Vietnam Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Table Central & South America Montelukast Intermediate Sales Forecast by Countries 2019-2025 (MT)
Table Central & South America Montelukast Intermediate Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Montelukast Intermediate Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Montelukast Intermediate Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Table Middle East and Africa Montelukast Intermediate Sales Forecast by Regions 2019-2025 (MT)
Table Middle East and Africa Montelukast Intermediate Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Montelukast Intermediate Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Montelukast Intermediate Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Figure GCC Countries Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Figure Egypt Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Figure South Africa Montelukast Intermediate Sales Forecast 2019-2025 (MT)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
アレルギー性鼻炎治療の世界市場：市場規模・現状・予測 The common name for allergic rhinitis is hay fever. It is diagnosed when symptoms appear which includes itchy nose, mouth, eyes, throat, skin, as well as other parts of the body; along with this other symptoms includes running nose, sneezing, watery eyes, problem during smelling, cough and sore th…- 通年性アレルギー性鼻炎の世界市場：市場規模・現状・予測 In 2018, the global Perennial Allergic Rhinitis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Perennial Allergic Rhinitis status, future forecast, growth opportunity, key market and…
- API中間体の世界市場：インサイト・予測 API intermediates are compounds or agents used as raw materials for the formulation of active pharmaceutical ingredients (API).The global API Intermediate market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objec…
- 世界の複合中間合金市場：専門的調査 An interstitial compound, or interstitial alloy, is a compound that is formed when an atom with a small enough radius sits in an interstitial “hole” in a metal lattice. The global Compound Intermediate Alloy market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025…
- 世界の再調整中間バルクコンテナ市場：専門的調査 An intermediate bulk container is a pallet mounted, industrial grade reusable container that is used for storing and transporting bulk liquids and powders. The global Reconditioned Intermediate Bulk Containers market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 20…